The Changes of Interleukin 17 levels On Pulmonary Tuberculosis Patients with AFB Smear-Positive After 2 Months Anti Tuberculosis Drugs Treatment | Zendy

Andy Sulaiman Siregar | Zendy; Soedarsono Soedarsono | Zendy

Open Access

The Changes of Interleukin 17 levels On Pulmonary Tuberculosis Patients with AFB Smear-Positive After 2 Months Anti Tuberculosis Drugs Treatment

Author(s) -

Andy Sulaiman Siregar,

Soedarsono Soedarsono

Publication year - 2019

Publication title -

jurnal respirologi indonesia

Language(s) - English

Resource type - Journals

eISSN - 2620-3162

pISSN - 0853-7704

DOI - 10.36497/jri.v38i4.23

Subject(s) - medicine , tuberculosis , pulmonary tuberculosis , observational study , prospective cohort study , gastroenterology , cohort , cohort study , surgery , pathology

Background: Tuberculosis still remain as a health problem in the world. No specific biomarkers can be used to monitor the rapid response to TB therapy. This study aims to assess the change of IL-17 levels in pulmonary tuberculosis patients with AFB smear-positive before and after 2 months of anti tuberculosis drugs (ATD) treatment. Method: Design of study is analytic observational with prospective cohort. The subject include 17 new cases of pulmonary tuberculosis patients with AFB smear-positive in Soetomo Hospital Surabaya from July - October 2016. Plasma levels of IL-17 were measured using ELISA technique before treatment and 2 months after the ATD therapy. Results: The mean levels of IL-17 before treatment is 3.510 pg / ml (2.087- 5.051 pg/ml). There were significantly decreament (p = 0.001

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research